Detalles de la búsqueda
1.
Real-World Use of Hypofractionated Radiotherapy for Primary CNS Tumors in the Elderly, and Implications on Medicare Spending.
J Natl Compr Canc Netw
; 22(4)2024 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38688308
2.
Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.
J Neurooncol
; 166(2): 351-357, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244173
3.
The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review.
J Neurooncol
; 167(1): 1-34, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294638
4.
Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
J Neurooncol
; 168(1): 1-11, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38619777
5.
Social cognition and adjustment in adult survivors of pediatric central nervous system tumors.
Cancer
; 129(19): 3064-3075, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37329245
6.
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study.
J Neurooncol
; 164(3): 643-653, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768471
7.
Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
J Neurooncol
; 162(2): 353-362, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951945
8.
Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
Acta Oncol
; 62(6): 648-656, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338525
9.
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy.
Curr Treat Options Oncol
; 24(11): 1524-1549, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37728819
10.
Critical Appraisal of Proton Therapy for Patients with Central Nervous System (CNS) Malignancies.
Curr Treat Options Oncol
; 24(8): 988-1003, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212933
11.
Radiotherapy for Primary Pediatric Central Nervous System Malignancies: Current Treatment Paradigms and Future Directions.
Pediatr Neurosurg
; 58(5): 356-366, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37703864
12.
Brachytherapy for central nervous system tumors.
J Neurooncol
; 158(3): 393-403, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546384
13.
Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphoma.
J Neurooncol
; 156(2): 307-316, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34853952
14.
Risk of cerebrovascular disease among 13 457 five-year survivors of childhood cancer: A population-based cohort study.
Int J Cancer
; 148(3): 572-583, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683688
15.
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapy.
J Neurooncol
; 154(2): 207-217, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34331673
16.
Radiation therapy for infants with cancer.
Pediatr Blood Cancer
; 68 Suppl 2: e28700, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818894
17.
Outcome of patients with newly diagnosed primary CNS lymphoma after high-dose methotrexate followed by consolidation whole-brain radiotherapy and cytarabine: an 8-year cohort study.
Int J Clin Oncol
; 26(10): 1805-1811, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34236556
18.
Molecular Biology in Treatment Decision Processes-Neuro-Oncology Edition.
Int J Mol Sci
; 22(24)2021 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34948075
19.
Treatment of relapsed/refractory paediatric aggressive B-cell non-Hodgkin lymphoma.
Br J Haematol
; 189(5): 826-843, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32141616
20.
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Br J Haematol
; 189(5): 879-887, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997308